Implications for HIV elimination by 2030 of recent trends in undiagnosed infection in England: an evidence synthesis

A target to eliminate Human Immuno-deficiency Virus (HIV) transmission in England by 2030 was set in early 2019. Estimates of recent trends in HIV prevalence, particularly the number of people living with undiagnosed HIV, by exposure group, ethnicity, gender, age group and region, are essential to monitor progress towards elimination. A Bayesian synthesis of evidence from multiple surveillance, demographic and survey datasets relevant to HIV in England is employed to estimate trends in: the number of people living with HIV (PLWH); the proportion of these people unaware of their HIV infection; and the corresponding prevalence of undiagnosed HIV. All estimates are stratified by exposure group, ethnicity, gender, age group (15-34, 35-44, 45-59, 60-74), region (London, outside London) and year (2012-2017). The total number of PLWH aged 15-74 in England increased from 82,400 (95% credible interval, CrI, 78,700 to 89,100) in 2012 to 89,500 (95% CrI 87,400 to 93,300) in 2017. The proportion diagnosed steadily increased from 84% (95% CrI 77 to 88%) to 92% (95% CrI 89 to 94%) over the same time period, corresponding to a halving in the number of undiagnosed infections from 13,500 (95% CrI 9,800 to 20,200) to 6,900 (95% CrI 4,900 to 10,700). This decrease is equivalent to a halving in prevalence of undiagnosed infection and is reflected in all sub-groups of gay, bisexual and other men who have sex with men and most sub-groups of black African heterosexuals. However, decreases were not detected for some sub-groups of other ethnicity heterosexuals, particularly outside London. In 2016, the Joint United Nations Programme on HIV/ AIDS target of diagnosing 90% of people living with HIV was reached in England. To achieve HIV elimination by 2030, current testing efforts should be enhanced to address the numbers of heterosexuals living with undiagnosed HIV, especially outside London.

[1]  Anne M Johnson,et al.  Combination prevention and HIV: a cross-sectional community survey of gay and bisexual men in London, October to December 2016 , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  M. Plummer,et al.  Extending Bayesian back-calculation to estimate age and time specific HIV incidence , 2019, Lifetime Data Analysis.

[3]  C. Thorne,et al.  National audit of perinatal HIV infections in the UK, 2006–2013: what lessons can be learnt? , 2018, HIV medicine.

[4]  S. Conti,et al.  Monitoring of the HIV Epidemic Using Routinely Collected Data: The Case of the United Kingdom , 2017, AIDS and Behavior.

[5]  A. Sullivan,et al.  An effective strategy to diagnose HIV infection: findings from a national audit of HIV partner notification outcomes in sexual health and infectious disease clinics in the UK , 2016, Sexually Transmitted Infections.

[6]  C. Leen,et al.  British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015 , 2016, HIV medicine.

[7]  Anne M Johnson,et al.  The health and well-being of men who have sex with men (MSM) in Britain: Evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) , 2016, BMC Public Health.

[8]  Richard G. White,et al.  Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study. , 2016, The lancet. HIV.

[9]  Sheena McCormack,et al.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial , 2016, The Lancet.

[10]  H. Mohammed,et al.  Improving surveillance of sexually transmitted infections using mandatory electronic clinical reporting: the genitourinary medicine clinic activity dataset, England, 2009 to 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  Daniela De Angelis,et al.  Estimation of HIV Burden through Bayesian Evidence Synthesis , 2014, 1405.4679.

[12]  H. Hospers,et al.  The European Men-Who-Have-Sex-With-Men Internet Survey (EMIS): Design and Methods , 2013 .

[13]  Paul J. Birrell,et al.  HIV incidence in men who have sex with men in England and Wales 2001–10: a nationwide population study , 2013, The Lancet. Infectious diseases.

[14]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[15]  D. De Angelis,et al.  Estimating the prevalence of ex-injecting drug use in the population , 2009, Statistical methods in medical research.

[16]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[17]  Catherine H Mercer,et al.  Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data , 2008 .

[18]  B. Gazzard British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008 , 2005, HIV medicine.

[19]  O. N. Gill,et al.  Progress towards ending the HIV epidemic in the United Kingdom: 2018 report. Data to end of December 2017. , 2019 .

[20]  A. Nardone,et al.  Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation. , 2018, The Lancet. Infectious diseases.

[21]  G. Hay,et al.  Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2009/10: Sweep 6 report , 2011 .

[22]  P. Vickerman,et al.  Shooting Up: Infections among people who inject drugs in the UK, 2018-an update, December 2019 , 2011 .

[23]  Ruth King Estimating Prevalence of Injecting Drug Users and As- sociated Death Rates in England Using Regional Data and Incorporating Prior Information , 2010 .

[24]  Hiv UK national guidelines for HIV testing. , 2008 .

[25]  S. Haeghebaert,et al.  BULLETIN EUROPÉEN SUR LES MALADIES TRANSMISSIBLES / EUROPEAN COMMUNICABLE DISEASE BULLETIN , 2003 .